Prescription Drug Patents: Balancing Innovation, Access, and Affordability



Priti Krishtel I-MAK, Co-Founder and Co-Executive Director
Genia Long Analysis Group, Senior Advisor
Ed Silverman STAT, Pharmalot Columnist


Experts and analysts

Joseph Antos American Enterprise Institute, Wilson H. Taylor Scholar in Health Care and Retirement Policy   202-862-5983
Peter Barton Hutt Covington & Burling LLP, Senior Counsel; Harvard Law School, Lecturer on Food and Drug Law   202-662-5522
Michael A. Carrier Rutgers Law School, Distinguished Professor of Law; Rutgers Institute for Information Policy and Law, Co-Director   856-225-6380
Rena Conti Boston University Institute for Health System Innovation & Policy, Associate Research Director of Biopharma & Public Policy
Henry G. Grabowski Duke University, Professor Emeritus of Economics
Doug Holtz-Eakin American Action Forum, President
Ameet Sarpatwari Harvard Medical School, Instructor in Medicine; Brigham Women’s Hospital, Assistant Director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine
Jeremy Sharp Waxman Strategies, Senior Vice President   202-684-8237  



Anna Abram Food and Drug Administration, Deputy Commissioner for Policy, Planning, Legislation and Analysis
Elizabeth Jex Federal Trade Commission, Attorney Advisor for the Office of Policy Planning



Lauren Aronson Campaign for Sustainable Rx Pricing, Executive Director   202-585-0255
Andrew Barnhill GlaxoSmithKline, Director of Federal Policy and HHS Strategy
Kristin Bass Pharmaceutical Care Management Association, Chief Policy and External Affairs Officer   202-756-5700
Adam J. Fein Drug Channels Institute, Chief Executive Officer   215-523-5700
Jennifer Jones Blue Cross Blue Shield Association, Legislative and Regulatory Policy Director
Erik Komendant Association for Accessible Medicines, Vice President of Federal Affairs
David Mitchell Patients for Affordable Drugs, President and Founder
Leigh Purvis AARP Health Policy Institute, Director of Health Services Research   202-434-3890
Andrew Rosenberg The Biosimilars Forum, Executive Director   202-688-0223
Sylvia Trujillo American Medical Association, Senior Washington Counsel   202-789-7481

Polly Webster Kaiser Permanente, Senior Policy Advisor

Tom Wilbur Pharmaceutical Research and Manufacturers of America, Director of Public Affairs   202-835-3400


The Alliance for Health Policy gratefully acknowledges the support of the National Institute of Health Care Management (NIHCM) Foundation and the Association of Health Care Journalists (AHCJ) for this event.